1999
Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support
Winer E, Lindley C, Hardee M, Sawyer W, Brunatti C, Borstelmann N, Peters W. Quality of life in patients surviving at least 12 months following high dose chemotherapy with autologous bone marrow support. Psycho-Oncology 1999, 8: 167-176. PMID: 10335560, DOI: 10.1002/(sici)1099-1611(199903/04)8:2<167::aid-pon354>3.0.co;2-s.Peer-Reviewed Original ResearchConceptsFunctional Living Index-CancerHigh-dose chemotherapyQuality of lifeAutologous bone marrow supportBone marrow supportSymptom Distress ScaleDose chemotherapyBreast cancerMarrow supportSexual functioningMajority of patientsBreast cancer patientsLong-term outcomesTreatment of patientsMore yearsFLIC scoresTransplant supportIndex cancerRecurrent diseaseAssessment of qualityMedian timeCancer patientsSexual functionClinical trialsSevere symptoms
1998
Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer.
Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. Journal Of Clinical Oncology 1998, 16: 1380-7. PMID: 9552041, DOI: 10.1200/jco.1998.16.4.1380.Peer-Reviewed Original ResearchConceptsFunctional Living Index-CancerQuality of lifeEarly-stage breast cancerSystemic adjuvant therapyMonths of chemotherapySymptom Distress ScaleAdjuvant therapySexual functionBreast cancerSevere symptomsMedical Outcomes Study Short Form-36Self-rated QOLThird of patientsMajority of patientsShort Form-36Breast cancer patientsPatient's physical symptomsSite of surgeryModest potential benefitAdjuvant cytotoxicAdjuvant treatmentHormonal therapyIndex cancerForm-36Local numbness